Schedule 13D ownership disclosure
THESEUS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 88369M101
Event date: 2024-02-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 100.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-24-003018
- Form type
- SC 13D
- Filer
- TANG CAPITAL PARTNERS LP
- CIK
- CIK 1191935
- Filed
- Feb 16, 2024
- Reporting period
- Feb 14, 2024
- Description
- Schedule 13D beneficial ownership